Literature DB >> 24472146

Antimycobacterial evaluation of novel hybrid arylidene thiazolidine-2,4-diones.

Singanan Ponnuchamy1, Selvaraj Kanchithalaivan2, Raju Ranjith Kumar3, Mohamed Ashraf Ali4, Tan Soo Choon5.   

Abstract

A series of novel hybrid heterocycles comprising arylidene thiazolidine-2,4-dione and 1-cyclopropyl-2-(2-fluorophenyl)ethanone were synthesized. These compounds were evaluated for their antimycobacterial activity against Mycobacterium tuberculosis H37Rv in High Throughput Screen. Most of the hybrid arylidene thiazolidine-2,4-diones displayed moderate to good activity with MIC of less than 50 μM. Compound 1m exhibited maximum potency being 5.87 fold more active at EC50 and 6.26 fold more active at EC90 than the standard drug pyrimethamine.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimycobacterial activity; High Throughput Screen; Knoevenagel condensation; Mycobacterium tuberculosis; Thiazolidine-2,4-dione

Mesh:

Substances:

Year:  2014        PMID: 24472146     DOI: 10.1016/j.bmcl.2014.01.007

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Synthesis of thiazolidine-2,4-dione derivatives: anticancer, antimicrobial and DNA cleavage studies.

Authors:  S Vijaya Laxmi; P Anil; G Rajitha; Asha Jyothi Rao; Peter A Crooks; B Rajitha
Journal:  J Chem Biol       Date:  2016-07-15

Review 2.  Genomics and Evolution in Traditional Medicinal Plants: Road to a Healthier Life.

Authors:  Da-Cheng Hao; Pei-Gen Xiao
Journal:  Evol Bioinform Online       Date:  2015-10-04       Impact factor: 1.625

3.  Design, synthesis, in silico studies and biological evaluation of 5-((E)-4-((E)-(substituted aryl/alkyl)methyl)benzylidene)thiazolidine-2,4-dione derivatives.

Authors:  Harsh Kumar; Aakash Deep; Rakesh Kumar Marwaha
Journal:  BMC Chem       Date:  2020-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.